Healing of protein losing hypertrophic gastropathy by eradication of Helicobacter pylori--is Helicobacter pylori a pathogenic factor in Ménétrier's disease?

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMC 1374761)

Published in Gut on May 01, 1994

Authors

E Bayerdörffer1, M M Ritter, R Hatz, W Brooks, G Ruckdeschel, M Stolte

Author Affiliations

1: Medical Department II, Klinikum Grosshadern, University of Munich, Germany.

Articles cited by this

Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med (1991) 23.89

Topographic association between active gastritis and Campylobacter pylori colonisation. J Clin Pathol (1989) 2.09

Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet (1985) 2.03

Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology (1992) 1.70

The natural history of hypertrophic gastrophy (Menetrier's disease). Report of a case with 16 year follow-up and review of 120 cases from the literature. Am J Med (1977) 1.67

Menetrier's disease. Spontaneous metamorphosis of giant hypertrophy of the gastric mucosa to atrophic gastritis. Gastroenterology (1967) 1.26

Ménétrier's disease and Helicobacter pylori. N Engl J Med (1993) 1.09

Hypertrophic, hypersecretory protein-losing gastropathy. Gastroenterology (1970) 1.04

[Helicobacter pylori-associated hypertrophic gastritis. Imitation of Ménétrier disease]. Fortschr Med (1992) 0.96

Campylobacter-like organisms in patient with Ménétrier's disease. Lancet (1988) 0.94

Ménétrier's disease. A trivalent gastropathy. Ann Surg (1988) 0.91

Increased tight junction width in two children with Ménétrier's disease. J Pediatr Gastroenterol Nutr (1990) 0.87

Campylobacter pylori, hypertrophic erosive gastritis and hypoalbuminemia healed by cephalexin therapy. Gastroenterol Clin Biol (1989) 0.80

Spontaneous remission of protein-losing gastropathy associated with Menetrier's disease. A plea for conservative management. Arch Intern Med (1980) 0.80

Campylobacter gastritis simulating Menetrier's disease by upper gastrointestinal radiography. Pediatr Radiol (1990) 0.80

Articles by these authors

The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39

Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet (1997) 7.59

Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet (1995) 6.32

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med (1998) 4.66

Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology (1997) 4.59

Differences in diagnostic criteria for esophageal squamous cell carcinoma between Japanese and Western pathologists. Cancer (2000) 4.55

Differences in the diagnostic criteria used by Japanese and Western pathologists to diagnose colorectal carcinoma. Cancer (1998) 3.98

Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut (2004) 3.80

Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst (1997) 3.30

Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther (1997) 3.02

Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut (2008) 2.93

Non-alcoholic duct destructive chronic pancreatitis. Gut (1997) 2.79

Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology (1999) 2.72

Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg (1996) 2.69

Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology (2000) 2.66

Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group. Gut (2000) 2.52

[Meta-analyses are hardly suitable for conclusively proving medical controversies]. Z Gastroenterol (1996) 2.47

Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood (1990) 2.42

Tandem genes encode cell-surface polypeptides SspA and SspB which mediate adhesion of the oral bacterium Streptococcus gordonii to human and bacterial receptors. Mol Microbiol (1996) 2.21

[On demonstration of E. coli O 91 in dyspepsia]. Zentralbl Bakteriol Orig (1966) 2.20

Topographic association between active gastritis and Campylobacter pylori colonisation. J Clin Pathol (1989) 2.09

Attempted endoscopic en bloc resection of mucosal and submucosal tumors using insulated-tip knives: a pilot series. Endoscopy (2004) 2.07

Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis. Am J Gastroenterol (2000) 2.03

Diagnostic criteria for gastrointestinal carcinomas in Japan and Western countries: proposal for a new classification system of gastrointestinal epithelial neoplasia. J Gastroenterol Hepatol (2000) 2.01

Comparison of histological parameters for the diagnosis of eosinophilic oesophagitis versus gastro-oesophageal reflux disease on oesophageal biopsy material. Histopathology (2008) 1.97

Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia. Endoscopy (2007) 1.94

Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. Gastrointest Endosc (2000) 1.94

Review of histological classifications of gastrointestinal epithelial neoplasia: differences in diagnosis of early carcinomas between Japanese and Western pathologists. J Gastroenterol (2001) 1.93

One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol (1995) 1.93

Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology (1998) 1.92

Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment Pharmacol Ther (2003) 1.91

Pyloric gland adenoma: a clinico-pathological analysis of 90 cases. Virchows Arch (2003) 1.82

Gastric carcinoma risk index in patients infected with Helicobacter pylori. Virchows Arch (1998) 1.79

Modulation of T-cell function by gliomas. Immunol Today (1991) 1.78

["A sick public health services watches over health status": how the former Federal Public Health Office turned German medicine exemplified by "omeprazole and blindness" into an international joke]. Leber Magen Darm (1994) 1.78

Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study. Aliment Pharmacol Ther (2011) 1.76

Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection. Gastroenterology (2000) 1.76

Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology (1997) 1.75

Eosinophil infiltration and degranulation in oesophageal mucosa from adult patients with eosinophilic oesophagitis: a retrospective and comparative study on pathological biopsy. J Clin Pathol (2006) 1.75

Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut (2004) 1.73

Prevalence of intestinal metaplasia in Helicobacter pylori gastritis. Scand J Gastroenterol (1994) 1.73

Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology (1992) 1.70

[Antibiotic effects of mixtures of polymethlmethacrylate with antibiotics]. Arch Orthop Unfallchir (1970) 1.68

Photodynamic ablation of early cancers of the stomach by means of mTHPC and laser irradiation: preliminary clinical experience. Gut (1998) 1.67

Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology (1996) 1.67

ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology (1999) 1.66

Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut (2004) 1.62

A special form of segmental pancreatitis: "groove pancreatitis". Hepatogastroenterology (1982) 1.62

Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia (2004) 1.59

Animal reservoirs in the transmission of Helicobacter heilmannii. Results of a questionnaire-based study. Scand J Gastroenterol (1998) 1.58

Effects of pentachlorophenol and some of its known and possible metabolites on fungi. Appl Environ Microbiol (1986) 1.58

Histological analysis of endoscopic resection specimens from 326 patients with Barrett's esophagus and early neoplasia. Endoscopy (2004) 1.58

Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study. Dig Liver Dis (2006) 1.57

Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology (1996) 1.53

Comparison of methylene blue-directed biopsies and four-quadrant biopsies in the detection of high-grade intraepithelial neoplasia and early cancer in Barrett's oesophagus. Dig Liver Dis (2006) 1.53

Usefulness of exhaled nitric oxide to guide risk stratification for bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant (2010) 1.52

The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter pylori infection. Am J Gastroenterol (2000) 1.52

Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol (2004) 1.49

Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial. Gut (2002) 1.48

Efficacy of omeprazole one year after cure of Helicobacter pylori infection in duodenal ulcer patients. Am J Gastroenterol (1997) 1.48

Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol (2004) 1.47

Helicobacter pylori gastritis and primary gastric non-Hodgkin's lymphomas. J Clin Pathol (1994) 1.47

The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int J Cancer (2000) 1.46

Diagnostic accuracy of forceps biopsy versus polypectomy for gastric polyps: a prospective multicentre study. Gut (2002) 1.43

Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks. Metabolism (2001) 1.42

Susceptibility of Legionella spp. to quinolone derivatives and related organic acids. Eur J Clin Microbiol (1984) 1.42

[Echinococcosis--current status of diagnosis and therapy]. Leber Magen Darm (1993) 1.41

Cure of gastric ulcer disease after cure of Helicobacter pylori infection--German Gastric Ulcer Study. Eur J Gastroenterol Hepatol (1996) 1.40

Legionella infection of the colon presenting as acute attack of ulcerative colitis. Gastroenterology (1989) 1.40

[Operation technique determines frequency of recurrence of colorectal carcinoma]. Chirurg (1999) 1.40

Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther (2003) 1.40

[The status of diagnosis of Barrett esophagus. An analysis of 1000 histologically diagnosed cases]. Dtsch Med Wochenschr (1997) 1.39

[Order in the chaos of classifications of erosions of the gastric mucosa]. Leber Magen Darm (1993) 1.39

[Is lack of stomach carcinoma prevention by Helicobacter pylori eradication unethical?]. Z Gastroenterol (1999) 1.39

Role of adherence in interleukin-8 induction in Helicobacter pylori-associated gastritis. Infect Immun (1997) 1.38

Giardiasis: a histologic analysis of 567 cases. Scand J Gastroenterol (1997) 1.38

[Cost-benefit analysis of conservative therapy of gastritis and peptic ulcer]. Leber Magen Darm (1994) 1.37

[Bleeding peptic ulcers--how can recurrent bleeding be prevented?]. Leber Magen Darm (1995) 1.37

Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). World J Gastroenterol (2001) 1.35

High proportion of large genomic deletions and a genotype phenotype update in 80 unrelated families with juvenile polyposis syndrome. J Med Genet (2007) 1.34

Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection. J Clin Oncol (2001) 1.34

Adenoma and carcinoma of the duodenum and papilla of Vater: a clinicopathologic study. Am J Gastroenterol (1992) 1.33

Prevention of colonization and respiratory infections in long-term ventilated patients by local antimicrobial prophylaxis. Intensive Care Med (1987) 1.31

Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease. Am J Gastroenterol (1999) 1.31

Beta 2-microglobulin-deficient mice are protected from hypergammaglobulinemia and have defective antibody responses because of increased IgG catabolism. J Immunol (1997) 1.31

Effect of curing Helicobacter pylori infection on intragastric pH during treatment with omeprazole. Gut (1995) 1.30

Gastric MALT lymphoma and its relationship to Helicobacter pylori infection: management and pathogenesis of the disease. Microsc Res Tech (2000) 1.29

Polymerase chain reaction versus culture for detection of Ureaplasma urealyticum and Mycoplasma hominis in the urogenital tract of adults and the respiratory tract of newborns. Eur J Clin Microbiol Infect Dis (1996) 1.29

Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type. World J Gastroenterol (2001) 1.28

KTP laser destruction of dysplasia and early cancer in columnar-lined Barrett's esophagus. Gastrointest Endosc (1999) 1.28

Analysis of symptoms and endoscopic findings in 117 patients with histological diagnoses of eosinophilic esophagitis. Endoscopy (2007) 1.27

Relationship between diseases of the pancreas and hyperplasia of Brunner's glands. Virchows Arch A Pathol Anat Histol (1981) 1.27

Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease. Gastroenterology (1997) 1.27

[Qualitative and semiquantitative invasive and noninvasive diagnosis of Helicobacter pylori colonization of gastric mucosa]. Z Gastroenterol (1993) 1.26